» Articles » PMID: 28447622

Modern Clinical Research on LSD

Overview
Date 2017 Apr 28
PMID 28447622
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

All modern clinical studies using the classic hallucinogen lysergic acid diethylamide (LSD) in healthy subjects or patients in the last 25 years are reviewed herein. There were five recent studies in healthy participants and one in patients. In a controlled setting, LSD acutely induced bliss, audiovisual synesthesia, altered meaning of perceptions, derealization, depersonalization, and mystical experiences. These subjective effects of LSD were mediated by the 5-HT receptor. LSD increased feelings of closeness to others, openness, trust, and suggestibility. LSD impaired the recognition of sad and fearful faces, reduced left amygdala reactivity to fearful faces, and enhanced emotional empathy. LSD increased the emotional response to music and the meaning of music. LSD acutely produced deficits in sensorimotor gating, similar to observations in schizophrenia. LSD had weak autonomic stimulant effects and elevated plasma cortisol, prolactin, and oxytocin levels. Resting-state functional magnetic resonance studies showed that LSD acutely reduced the integrity of functional brain networks and increased connectivity between networks that normally are more dissociated. LSD increased functional thalamocortical connectivity and functional connectivity of the primary visual cortex with other brain areas. The latter effect was correlated with subjective hallucinations. LSD acutely induced global increases in brain entropy that were associated with greater trait openness 14 days later. In patients with anxiety associated with life-threatening disease, anxiety was reduced for 2 months after two doses of LSD. In medical settings, no complications of LSD administration were observed. These data should contribute to further investigations of the therapeutic potential of LSD in psychiatry.

Citing Articles

Lumpy Skin Disease: Insights into Molecular Pathogenesis and Control Strategies.

Haider A, Abbas Z, Taqveem A, Ali A, Khurshid M, El Naggar R Vet Sci. 2024; 11(11).

PMID: 39591335 PMC: 11598853. DOI: 10.3390/vetsci11110561.


Psychedelics and schizophrenia: a double-edged sword.

Sapienza J, Martini F, Comai S, Cavallaro R, Spangaro M, De Gregorio D Mol Psychiatry. 2024; 30(2):679-692.

PMID: 39294303 DOI: 10.1038/s41380-024-02743-x.


LSD Modulates Proteins Involved in Cell Proteostasis, Energy Metabolism and Neuroplasticity in Human Cerebral Organoids.

N Costa M, Goto-Silva L, M Nascimento J, Domith I, Karmirian K, Feilding A ACS Omega. 2024; 9(34):36553-36568.

PMID: 39220485 PMC: 11360045. DOI: 10.1021/acsomega.4c04712.


Deciphering the Causality between Gut Microbiota Dysbiosis and Poisoning by Narcotics and Psychodysleptics: A Mendelian Randomization Analysis.

Wang N, Su Z Curr Neuropharmacol. 2024; 23(2):187-195.

PMID: 39082168 PMC: 11793043. DOI: 10.2174/1570159X22999240729092453.


Investigating the impact of psychedelic drugs on social cognition defects: A scoping review protocol.

Smith S, Smith S, Dennett L, Zhang Y PLoS One. 2024; 19(7):e0307491.

PMID: 39074107 PMC: 11285908. DOI: 10.1371/journal.pone.0307491.


References
1.
Griffiths R, Johnson M, Richards W, Richards B, McCann U, Jesse R . Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Psychopharmacology (Berl). 2011; 218(4):649-65. PMC: 3308357. DOI: 10.1007/s00213-011-2358-5. View

2.
Studerus E, Kometer M, Hasler F, Vollenweider F . Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies. J Psychopharmacol. 2010; 25(11):1434-52. DOI: 10.1177/0269881110382466. View

3.
Carhart-Harris R, Leech R, Erritzoe D, Williams T, Stone J, Evans J . Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis. Schizophr Bull. 2012; 39(6):1343-51. PMC: 3796071. DOI: 10.1093/schbul/sbs117. View

4.
Krebs T, Johansen P . Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials. J Psychopharmacol. 2012; 26(7):994-1002. DOI: 10.1177/0269881112439253. View

5.
Kaelen M, Roseman L, Kahan J, Santos-Ribeiro A, Orban C, Lorenz R . LSD modulates music-induced imagery via changes in parahippocampal connectivity. Eur Neuropsychopharmacol. 2016; 26(7):1099-109. DOI: 10.1016/j.euroneuro.2016.03.018. View